comprehensive -WSS

comprehensive

author：fashion 2025-09-06 04:37:43 - browse：36297

Investment bank Goldman Sachs is jumping into the biotech world after raising $650 million to invest in privately held startups.

The bank announced Wednesday that it has closed its first-ever life sciences fund, called West Street Life Sciences I. The plan is to invest the money in genetic medicine, cell therapies, immunotherapies, synthetic biology and artificial intelligence startups, as well as diagnostics and life science tools companies.

First-time funds have been difficult to raise during the biotech downturn. Last year, around $11.6 billion was raised by 183 new VC funds, which was the lowest fundraising total for first-timers since 2013, according to Pitchbook. Around $25.6 billion had been raised by 556 first-time funds in 2022.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： Medicare Advantage beneficiaries sue Humana over algorithm use

focus

WSS

What is STAT's opinion section for?

Violet CEO on training clinicians to promote more inclusive care

Prime Medicine, Myeloid Therapeutics clash over genome

Experimental asthma app from Apple and Anthem shows promise

Hospitals owned by private equity see complications spike 25%

Medical school prerequisites are outdated

Wikipedia

comprehensive

focus

Peter Hotez and the public health issue of online harassment

CRISPR gene editing developments we’re watching in 2024

As demand for Covid shots wanes, Moderna seeks its next success

Advocates call out 'SNL' over stereotypes, errors in sickle cell skit

Sports medicine is finally prioritizing gender equality

Carbon Health diabetes program, a test of data

United colonoscopy coverage change 'may cost lives,' doctors say

Cancer diagnosis changes perspective doctor, former hospital CEO

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Why health care costs have stayed mostly flat since 2010

explore

Drinking less cuts risk of oral cavity, esophageal cancer: Report

Healthy food access boosts outcomes in two studies

Why health care costs have stayed mostly flat since 2010

Christmas in the PICU brings some surprising joy

Advocates call out 'SNL' over stereotypes, errors in sickle cell skit

Bristol Myers buys into radiopharmaceuticals with RayzeBio

entertainment

hotspot

focus

hotspot